SI-BONE, Inc. (NASDAQ:SIBN) Holdings Reduced by Royce & Associates LP

Royce & Associates LP lowered its position in SI-BONE, Inc. (NASDAQ:SIBN) by 24.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 110,000 shares of the company’s stock after selling 35,000 shares during the quarter. Royce & Associates LP’s holdings in SI-BONE were worth $1,538,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Impax Asset Management Group plc increased its position in SI-BONE by 41.3% in the 3rd quarter. Impax Asset Management Group plc now owns 758,521 shares of the company’s stock valued at $10,604,000 after acquiring an additional 221,604 shares during the period. Harbor Capital Advisors Inc. increased its holdings in shares of SI-BONE by 222.5% during the third quarter. Harbor Capital Advisors Inc. now owns 620,490 shares of the company’s stock valued at $8,674,000 after purchasing an additional 428,110 shares during the period. Essex Investment Management Co. LLC bought a new stake in shares of SI-BONE during the third quarter valued at about $2,342,000. Diversified Trust Co lifted its holdings in SI-BONE by 27.6% in the third quarter. Diversified Trust Co now owns 27,160 shares of the company’s stock worth $380,000 after purchasing an additional 5,875 shares during the period. Finally, SG Americas Securities LLC acquired a new position in SI-BONE during the 3rd quarter valued at about $353,000. Institutional investors own 98.11% of the company’s stock.

SI-BONE Trading Down 0.3 %

Shares of NASDAQ:SIBN opened at $12.32 on Wednesday. The company has a debt-to-equity ratio of 0.22, a quick ratio of 7.22 and a current ratio of 8.25. The stock has a market capitalization of $516.70 million, a price-to-earnings ratio of -13.39 and a beta of 1.22. SI-BONE, Inc. has a 1-year low of $11.76 and a 1-year high of $21.70. The company has a 50 day moving average price of $13.91 and a 200 day moving average price of $14.26.

Insider Activity

In related news, insider Anthony J. Recupero sold 3,305 shares of SI-BONE stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $13.58, for a total value of $44,881.90. Following the transaction, the insider now directly owns 233,412 shares in the company, valued at $3,169,734.96. The trade was a 1.40 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. In the last 90 days, insiders sold 5,060 shares of company stock worth $72,621. Insiders own 3.90% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $19.00 price target on shares of SI-BONE in a research note on Wednesday, November 13th. Morgan Stanley decreased their price target on SI-BONE from $21.00 to $19.00 and set an “overweight” rating for the company in a research note on Tuesday, August 6th. Finally, Truist Financial boosted their price objective on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock currently has an average rating of “Buy” and an average target price of $23.00.

About SI-BONE

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.